Danielle Brill
Stock Analyst at Truist Financial
(4.80)
# 525
Out of 4,673 analysts
406
Total ratings
58.3%
Success rate
17.4%
Average return
Main Sectors:
Stocks Rated by Danielle Brill
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SLDB Solid Biosciences | Initiated Coverage: Buy | $20 | $9.30 | +115.05% | 1 | Aug 21, 2026 | |
| ARGX argenx SE | Rated: Buy | $1,030 → $1,095 | $1,039.78 | +5.31% | 34 | Aug 18, 2026 | |
| APGE Apogee Therapeutics | Maintained: Hold | $81 → $135 | $134.75 | +0.19% | 5 | Aug 13, 2026 | |
| MAZE Maze Therapeutics | Maintained: Buy | $64 | $29.43 | +117.47% | 5 | Aug 13, 2026 | |
| BBIO BridgeBio Pharma | Maintained: Buy | $102 → $107 | $81.50 | +31.29% | 15 | Aug 12, 2026 | |
| UPB Upstream Bio | Maintained: Buy | $43 → $25 | $6.97 | +258.68% | 7 | Aug 12, 2026 | |
| VRTX Vertex Pharmaceuticals | Maintained: Buy | n/a | $548.05 | - | 10 | Aug 11, 2026 | |
| IRON Disc Medicine | Maintained: Buy | n/a | $79.81 | - | 20 | Aug 11, 2026 | |
| CLYM Climb Bio | Maintained: Buy | $25 | $17.28 | +44.68% | 6 | Aug 11, 2026 | |
| INSM Insmed | Reiterated: Buy | $195 | $125.77 | +55.04% | 10 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 | $37.63 | +59.45% | 12 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $30 | $44.37 | -32.39% | 15 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $616 | $375.94 | +63.86% | 3 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $128 | $111.10 | +15.21% | 9 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $56 | $48.24 | +16.09% | 3 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $207 | $142.04 | +45.73% | 13 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $29 → $34 | $38.15 | -10.88% | 20 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $315 | $236.22 | +33.35% | 17 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $200 → $213 | $152.57 | +39.61% | 24 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $235 | $216.78 | +8.40% | 19 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $5.29 | +183.55% | 3 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $9.28 | $48.37 | n/a | 23 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $10.72 | n/a | 3 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $29.50 | n/a | 19 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $79 | $66.70 | n/a | 2 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $150 | $18.79 | n/a | 36 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $69.82 | n/a | 21 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $51 | $33.09 | n/a | 3 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $52 → $50 | $60.77 | n/a | 2 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $24.92 | n/a | 2 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $7.52 | n/a | 19 | Jun 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $24 → $10 | $4.44 | n/a | 5 | May 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $13.47 | n/a | 1 | Jun 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 → $45 | $11.03 | n/a | 2 | May 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $48.33 | n/a | 10 | Feb 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $125 | $207.77 | n/a | 1 | Dec 16, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 → $5 | $17.15 | n/a | 5 | Nov 7, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $146.12 | n/a | 1 | Jul 26, 2016 |
Solid Biosciences
Aug 21, 2026
Initiated Coverage: Buy
Price Target: $20
Current: $9.30
Upside: +115.05%
argenx SE
Aug 18, 2026
Rated: Buy
Price Target: $1,030 → $1,095
Current: $1,039.78
Upside: +5.31%
Apogee Therapeutics
Aug 13, 2026
Maintained: Hold
Price Target: $81 → $135
Current: $134.75
Upside: +0.19%
Maze Therapeutics
Aug 13, 2026
Maintained: Buy
Price Target: $64
Current: $29.43
Upside: +117.47%
BridgeBio Pharma
Aug 12, 2026
Maintained: Buy
Price Target: $102 → $107
Current: $81.50
Upside: +31.29%
Upstream Bio
Aug 12, 2026
Maintained: Buy
Price Target: $43 → $25
Current: $6.97
Upside: +258.68%
Vertex Pharmaceuticals
Aug 11, 2026
Maintained: Buy
Price Target: n/a
Current: $548.05
Upside: -
Disc Medicine
Aug 11, 2026
Maintained: Buy
Price Target: n/a
Current: $79.81
Upside: -
Climb Bio
Aug 11, 2026
Maintained: Buy
Price Target: $25
Current: $17.28
Upside: +44.68%
Insmed
Aug 10, 2026
Reiterated: Buy
Price Target: $195
Current: $125.77
Upside: +55.04%
Aug 10, 2026
Maintained: Buy
Price Target: $60
Current: $37.63
Upside: +59.45%
Aug 7, 2026
Maintained: Hold
Price Target: $30
Current: $44.37
Upside: -32.39%
Aug 7, 2026
Maintained: Buy
Price Target: $616
Current: $375.94
Upside: +63.86%
Aug 6, 2026
Maintained: Buy
Price Target: $128
Current: $111.10
Upside: +15.21%
Aug 6, 2026
Maintained: Buy
Price Target: $56
Current: $48.24
Upside: +16.09%
Aug 5, 2026
Reiterated: Buy
Price Target: $207
Current: $142.04
Upside: +45.73%
Aug 5, 2026
Maintained: Hold
Price Target: $29 → $34
Current: $38.15
Upside: -10.88%
Aug 4, 2026
Rated: Buy
Price Target: $315
Current: $236.22
Upside: +33.35%
Aug 3, 2026
Maintained: Buy
Price Target: $200 → $213
Current: $152.57
Upside: +39.61%
Jul 31, 2026
Reiterated: Buy
Price Target: $235
Current: $216.78
Upside: +8.40%
Jul 31, 2026
Maintained: Buy
Price Target: $15
Current: $5.29
Upside: +183.55%
Dec 10, 2024
Maintained: Buy
Price Target: $20 → $9.28
Current: $48.37
Upside: n/a
Nov 18, 2024
Reiterated: Buy
Price Target: $18
Current: $10.72
Upside: n/a
Oct 10, 2024
Initiated Coverage: Hold
Price Target: n/a
Current: $29.50
Upside: n/a
Oct 10, 2024
Initiated Coverage: Buy
Price Target: $79
Current: $66.70
Upside: n/a
Oct 10, 2024
Initiated Coverage: Buy
Price Target: $150
Current: $18.79
Upside: n/a
Oct 10, 2024
Initiated Coverage: Hold
Price Target: n/a
Current: $69.82
Upside: n/a
Oct 10, 2024
Initiated Coverage: Buy
Price Target: $51
Current: $33.09
Upside: n/a
Oct 10, 2024
Initiated Coverage: Buy
Price Target: $52 → $50
Current: $60.77
Upside: n/a
Oct 10, 2024
Initiated Coverage: Hold
Price Target: n/a
Current: $24.92
Upside: n/a
Jun 26, 2023
Downgraded: Hold
Price Target: n/a
Current: $7.52
Upside: n/a
May 16, 2022
Maintained: Buy
Price Target: $24 → $10
Current: $4.44
Upside: n/a
Jun 30, 2021
Initiated Coverage: Hold
Price Target: n/a
Current: $13.47
Upside: n/a
May 27, 2020
Maintained: Buy
Price Target: $35 → $45
Current: $11.03
Upside: n/a
Feb 13, 2020
Maintained: Hold
Price Target: n/a
Current: $48.33
Upside: n/a
Dec 16, 2019
Reiterated: Buy
Price Target: $125
Current: $207.77
Upside: n/a
Nov 7, 2019
Maintained: Hold
Price Target: $6 → $5
Current: $17.15
Upside: n/a
Jul 26, 2016
Downgraded: Hold
Price Target: n/a
Current: $146.12
Upside: n/a